Evidence map›Paper›PMID 22832159›Full record

ArticleCell reports2012

Long telomeres bypass the requirement for telomere maintenance in human tumorigenesis.

Michael A S Taboski, David C F Sealey, Jennifer Dorrens, Chandrakant Tayade, Dean H Betts, Lea Harrington

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Telomerase-Mediated Anti-Ageing Interventions.Sub-cellular biochemistry · 2024
    Review
  5. Review
  6. Article
  7. eLife · 2020
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Michael A S TaboskiCampbell Family Institute for Cancer Research and Department of Medical Biophysics, Ontario Cancer Institute, University of Toronto, Toronto, M5G 2C1, Canada.
David C F Sealey
Jennifer Dorrens
Chandrakant Tayade
Dean H Betts
Lea Harrington
University of Guelph · CAUniversity of Toronto · CAOntario Institute for Cancer Research · CAUniversity of Edinburgh · GB

Funding

A unique murine model for human agingR01AG024398 · NIA · UNIVERSITY HEALTH NETWORK · PI HARRINGTON, LEA A · 2004 to 2008
$1.4M
CIHR MOP-86453NIA NIH HHS R01 AG024398NIA NIH HHS R01-AG024398Wellcome Trust 092076Wellcome Trust 84637
6 · The paper itself

Abstract

Despite the importance of telomere maintenance in cancer cell survival via the elongation of telomeres by telomerase reverse transcriptase (TERT) or alternative lengthening of telomeres (ALT), it had not been tested directly whether telomere maintenance is dispensable for human tumorigenesis. We engineered human tumor cells containing loxP-flanked hTERT to enable extensive telomere elongation prior to complete hTERT excision. Despite unabated telomere erosion, hTERT-excised cells formed tumors in mice and proliferated in vitro for up to 1 year. Telomerase reactivation or ALT was not observed, and the eventual loss of telomeric signal coincided with loss of tumorigenic potential and cell viability. Crisis was averted via the reintroduction of active but not inactive hTERT. Thus, telomere maintenance is dispensable for human tumorigenesis when telomere reserves are long. Yet, despite telomere instability and the presence of oncogenic RAS, human tumors remain susceptible to crisis induced by critically short telomeres.

Indexed as

Telomere HomeostasisAnimalsBiocatalysisCell Line, TumorCell Transformation, NeoplasticHumansMiceMutationTelomeraseTelomereTelomerase

Identifiers

PMID22832159
PMCPMC3406325
OpenAlexW2115514668

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.